BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 26089142)

  • 1. Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout.
    Dantas Machado AC; Cooper BH; Lei X; Di Felice R; Chen L; Rohs R
    Nucleic Acids Res; 2020 Sep; 48(15):8529-8544. PubMed ID: 32738045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
    Magistri M; Happ LE; Ramdial J; Lu X; Stathias V; Kunkalla K; Agarwal N; Jiang X; Schürer SC; Dubovy SR; Chapman JR; Vega F; Dave S; Lossos IS
    Cancer Res Commun; 2021 Oct; 1(1):1-16. PubMed ID: 35528192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RELT stains prominently in B-cell lymphomas and binds the hematopoietic transcription factor MDFIC.
    Cusick JK; Alhomsy Y; Wong S; Talbott G; Uversky VN; Hart C; Hejazi N; Jacobs AT; Shi Y
    Biochem Biophys Rep; 2020 Dec; 24():100868. PubMed ID: 33367115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
    Magistri M; Happ LE; Ramdial J; Lu X; Stathias V; Kunkalla K; Agarwal N; Jiang X; Schürer SC; Dubovy SR; Chapman JR; Vega F; Dave S; Lossos IS
    Cancer Res Commun; 2023 Aug; 3(8):1688. PubMed ID: 37649813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation.
    Pon JR; Wong J; Saberi S; Alder O; Moksa M; Grace Cheng SW; Morin GB; Hoodless PA; Hirst M; Marra MA
    Nat Commun; 2015 Aug; 6():7953. PubMed ID: 26245647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking Prognosis and Therapy for Follicular Lymphoma.
    Jacobson CA; Freedman AS
    J Clin Oncol; 2015 Aug; 33(23):2489-91. PubMed ID: 26169620
    [No Abstract]   [Full Text] [Related]  

  • 7. MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis.
    Brescia P; Schneider C; Holmes AB; Shen Q; Hussein S; Pasqualucci L; Basso K; Dalla-Favera R
    Cancer Cell; 2018 Sep; 34(3):453-465.e9. PubMed ID: 30205047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
    Jovanovic MP; Mihaljevic B; Jakovic L; Martinovic VC; Fekete MD; Andjelic B; Antic D; Bogdanovic A; Boricic N; Terzic T; Jelicic J; Milenkovic S
    J BUON; 2015; 20(3):820-8. PubMed ID: 26214636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.
    Wei Z; Gao W; Wu Y; Ni B; Tian Y
    Clin Transl Oncol; 2015 Nov; 17(11):841-6. PubMed ID: 26108407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
    Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
    Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.
    Sen M; Kindsfather A; Danilova L; Zhang F; Colombo R; LaPorte MG; Kurland BF; Huryn DM; Wipf P; Herman JG
    Epigenetics; 2020; 15(6-7):604-617. PubMed ID: 31595832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis.
    Taylor J; Sendino M; Gorelick AN; Pastore A; Chang MT; Penson AV; Gavrila EI; Stewart C; Melnik EM; Herrejon Chavez F; Bitner L; Yoshimi A; Lee SC; Inoue D; Liu B; Zhang XJ; Mato AR; Dogan A; Kharas MG; Chen Y; Wang D; Soni RK; Hendrickson RC; Prieto G; Rodriguez JA; Taylor BS; Abdel-Wahab O
    Cancer Discov; 2019 Oct; 9(10):1452-1467. PubMed ID: 31285298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia.
    Vercruysse T; De Bie J; Neggers JE; Jacquemyn M; Vanstreels E; Schmid-Burgk JL; Hornung V; Baloglu E; Landesman Y; Senapedis W; Shacham S; Dagklis A; Cools J; Daelemans D
    Clin Cancer Res; 2017 May; 23(10):2528-2541. PubMed ID: 27780859
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.
    Walker CJ; Miranda MA; O'Hern MJ; McElroy JP; Coombes KR; Bundschuh R; Cohn DE; Mutch DG; Goodfellow PJ
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26330387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.
    El Jamal SM; Grada Z; El Dinali MH; Zhou H; Hassan SY; Saad AG; Gibson B; Zhou X; Abulsayen HA; Khadra HS; Friedman J; Shalaby H; Kadi A; Megahed M; Emberesh M; Teruya-Feldstein J; Firpo-Betancourt A; Haikel Y; Fraig M; Hassan M
    Lab Invest; 2019 Apr; 99(4):539-550. PubMed ID: 30446717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Follicular Helper T-Cell Markers with the Expression of the Follicular Homing Marker CXCR5 in Peripheral T-Cell Lymphomas-A Reappraisal of Follicular Helper T-Cell Lymphomas.
    Krenács L; Krenács D; Borbényi Z; Tóth E; Nagy A; Piukovics K; Bagdi E
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.
    Shafi O; Siddiqui G; Jaffry HA
    BMC Cancer; 2023 Dec; 23(1):1245. PubMed ID: 38110859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.
    Krenács D; Borbényi Z; Bedekovics J; Méhes G; Bagdi E; Krenács L
    Virchows Arch; 2015 Sep; 467(3):345-55. PubMed ID: 26089142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.